Metabolic Engineering for the Development and Manufacturing of Pharmaceuticals

Biocatalysis for the Pharmaceutical Industry: Discovery, Development, and Manufacturing

Volumn , Issue , 2009, Pages 247-271

  Lu, Dongping ^a   Williams, Philip G ^a   Wang, Guangyi ^a  

^a UNIVERSITY OF HAWAII   (United States)

Author keywords

GC MS, capillary electrophoresis (CE) MS; High pressure liquid chromatography (HPLC); Liquid chromatography (LC) tandem MS (MS MS); Metabolic engineering for pharmaceutical development and manufacture; Metabolic engineering tools; Metabolic flux analysis (MFA); Natural product manufacture for medicinal use; Polyketide pharmaceuticals production metabolic engineering; Polyketides antibiotics actinorhodin (ACT) and undecylprodigiosin (RED); Yeast cells engineered to taxoid biosynthesis reconstruction

Indexed keywords

EID: 84889462599     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470823163.ch12     Document Type: Chapter

References (132)

1. Strohl, W.R. (2000) Therole of natural products in a modern drug discovery program. DrugDiscovery Today, 5,39-41.
2. Newman, D.J. and Cragg, G.M. (2007) Natural products as sources of new drugs over the last 25 years. Journal of Natural Products, 70,461-477.
3. Zhang, L. and Demain, A.L. (2005) Natural Products, Drug Discovery and Therapeutic Medicine, The Humana Press, Totowa, NJ.
4. Nielsen, J. (2001) Metabolic engineering. Applied Microbiology and Biotechnology, 55,263-283.
5. Mashego, M.R., Rumbold, K., De Mey, M. et al. (2006) Microbial metabolomics: past, present and future methodologies. Biotechnology Letters, 29,1-16.
6. Khosla, C. and Keasling, J.D. (2003) Metabolic engineering for drug discovery and development. Nature Reviews Drug Discovery, 2,1019-1025.
7. Stephanopoulos, G. (1999) Metabolic fluxes and metabolic engineering. Metabolic Engineering, 1,1-11.
8. Raab, R.M., Tyo, K. and Stephanopoulos, G. (2005) Metabolic engineering. Advances in Biochemical Engineering/Biotechnology, 100,1-17.
9. Vemuri, G.N. and Aristidou, A.A. (2005) Metabolic engineering in the-omics era: elucidating and modulating regulatory networks. Microbiology and Molecular Biology Reviews, 69,197-216.
10. Iwatani, S., Yamada, Y. and Usuda, Y. (2008) Metabolic flux analysis in biotechnology processes. Biotechnology Letters, 30,791-799.
11. Kim, H.U., Kim, T.Y. and Lee, S.Y. (2008) Metabolic flux analysis and metabolic engineering of microorganisms. Molecular Biosystems, 4,113-120.
12. Kleijn, R.J., Liu, F., Winden, W.A.v. et al. (2007) Cytosolic NADPH metabolism in penicillin-G producing and non-producing chemostat cultures of Penicillium chrysogenum. Metabolic Engineering, 9,112-123.
13. Bro, C. and Nielsen, J. (2004) Impact of 'ome' analyses on inverse metabolic engineering. Metabolic Engineering, 6,204-211.
14. Bailey, J.E., Sburlati, A., Hatzimanikatis, V. et al. (2002) Inverse metabolic engineering: a strategy for directed genetic engineering of useful phenotypes. Biotechnology and Bioengineering, 79,568-579.
15. Jaluria, P., Betenbaugh, M., Konstantopoulos, K. and Shiloach, J. (2007) Enhancement of cell proliferation in various mammalian cell lines by gene insertion of a cyclin-dependent kinase homolog. BMC Biotechnology, 7,71.
16. Jaluria, P., Betenbaugh, M., Konstantopoulos, K. et al. (2006) Application of microarrays to identify and characterize genes involved in attachment dependence in HeLa cells. Metabolic Engineering, 9,241-251.
17. Askenazi, M., Driggers, E.M., Holtzman, D.A. et al. (2003) Integrating transcriptional and metabolite profiles to direct the engineering of lovastatin-producing fungal strains. Nature Biotechnology, 21,150-156.
18. Pennington, S.R., Wilkins, M.R., Hochstrasser, D.F. and Dunn, M.J. (1999) Proteome analysis: from protein characterization to biological function. Trends in Cell Biology, 7,168-173.
19. Park, S.J., Lee, S.Y., Cho, J. et al. (2005) Global physiological understanding and metabolic engineering of microorganisms based on omics studies. Applied Microbiology and Biotechnology, 68,567-579.
20. Nie, L., Wu, G., Culley, D.E. et al. (2007) Integrative analysis oftranscriptomic and proteomic data: challenges. Solutions and Applications. Critical Reviews in Biotechnology, 27,63-75.
21. Han, M.-J., Jeong, K.J., Yoo, J.-S. and Lee, S.Y. (2003) Engineering Escherichia coli for increased productivity of serine-rich proteins based on proteome profiling. Applied and Environmental Microbiology, 69,5772-5781.
22. Blüher, S. and Mantzoros, C.S. (2007) Leptin in reproduction. Current Opinion in Endocrinology, Diabetes and Obesity, 14,458-464.
23. Nauck, M.A. and Meier, J.J. (2005) Glucagon-like peptide 1 and its derivatives in the treatment of diabetes. Regulatory Peptides, 128,135-148.
24. Gutniak, M.K., Svartberg, J., Hellstrom, P.M. et al. (2001) Antidiabetogenic action of glucagon-like peptide-1 related to administration relative to meal intake in subjects with type 2 diabetes. Journal of Internal Medicine, 250,81-87.
25. Lee, D.-H., Kim, S.-G., Park, Y.-C. et al. (2007) Proteome analysis of recombinant Escherichia coli producing human glucagon-like peptide-1. Analytical Tools for Proteomics, 849,323-330.
26. Mashego, M.R., Rumbold, K., Mey, M.D. et al. (2006) Microbial metabolomics: past, present and future methodologies. Biotechnology Letters, 29,1-16.
27. Oldiges, M., Lütz, S., Pflug, S. et al. (2007) Metabolomics: current state and evolving methodologies and tools. Applied Microbiology and Biotechnology, 76,495-511.
28. Oldiges, M., Kunze, M., Degenring, D. et al. (2004) Stimulation, monitoring, and analysis of pathway dynamics by metabolic profiling in the aromatic amino acid pathway. Biotechnology Progress, 20,1623-1633.
29. Ketchum, R.E.B., Rithner, C.D., Qiu, D. et al. (2003) Taxus metabolomics: methyl jasmonate preferentially induces production of taxoids oxygenated at C-13 in Taxus x media cell cultures. Plant Metabolomics, 62,901-909.
30. Friehs, K. (2004) Plasmid copy number and plasmid stability. Advances in Biochemical Engineering/Biotechnology, 86,47-82.
31. Antoine, R. and Locht, C. (1992) Isolation and molecular characterization of a novel broad-host-range plasmid from Bordetella bronchiseptica with sequence similarities to plasmids from Gram-positive organisms. Molecular Microbiology, 6,1785-1799.
32. Ewering, C., Lutke-Eversloh, T., Luftmann, H. and Steinbuchel, A. (2002) Identification of novel sulfur-containing bacterial polyesters: biosynthesis of poly(3-hydroxy-S-propyl-ω-thioalkanoates) containing thioether linkages in the side chains. Microbiology (Reading, England), 148,1397-1406.
33. Overhage, J., Steinbuchel, A. and Priefert, H. (2002) Biotransformation of eugenol to ferulic acid by a recombinant strain of Ralstonia eutropha H16. Applied and Environmental Microbiology, 68,4315-4321.
34. Tao, L., Jackson, R.E. and Cheng, Q. (2005) Directed evolution of copy number of abroad host range plasmid for metabolic engineering. Evolutionary Engineering, 7,10-17.
35. Nacken, V., Achstetter, T. and Degryse, E. (1996) Probing the limits of expression levels by varying promoter strength and plasmid copy number in Saccharomyces cerevisiae. Gene, 175,253-260.
36. Müller, J., Dijl, J.V., Venema, G. and Bron, S. (1996) Cloning of heterologous genes specifying detrimental proteins on pUC-derived plasmids in Escherichia coli. Molecular Genetics and Genomics, 252,207-211.
37. Jones, K.L., Kim, S.-W. and Keasling, J.D. (2000) Low-copyplasmidscanperformaswellasorbetterthanhigh-copy plasmids for metabolic engineering of bacteria. Metabolic Engineering, 2,328-338.
38. Yazdani, S. and Mukherjee, K. (2004) Continuous-culture studies on the stability and expression of recombinant streptokinase in Escherichia coli. Bioprocess and Biosystems Engineering, 24,341-346.
39. Peredelchuk, M.Y. and Bennett, G.N. (1997) A method for construction of E. coli strains with multiple DNA insertions in the chromosome. Gene, 187,231-238.
40. Boyd, D., Weiss, D.S., Chen, J.C. and Beckwith, J. (2000) Towards single-copy gene expression systems making gene cloning physiologically relevant: lambda In Ch, a simple Escherichia coli plasmid-chromosome shuttle system. Journal of Bacteriology, 182,842-847.
41. Yu, D., Ellis, H.M., Lee, E.C. et al. (2000) An efficient recombination system for chromosome engineering in Escherichia coli. Proceedings of the National Academy of Sciences, 97,5978-5983.
42. Wang, Y. and Pfeifer, B.A. (2007) 6-Deoxyerythronolide B production through chromosomal localization of the deoxyerythronolide B synthase genes in E. coli. Metabolic Engineering, 10,33-38.
43. Keasling, J.D. (1999) Gene-expressiontoolsforthe metabolic engineering of bacteria. Trends in Biotechnology, 17,452-460.
44. Yuan, L.Z., Rouviere, P.E., LaRossa, R.A. and Suh, W. (2006) Chromosomal promoter replacement of the isoprenoid pathway for enhancing carotenoid production in E. coli. Metabolic Engineering, 8,79-90.
45. Kim, S.-W. and Keasling, J.D. (2001) Metabolic engineering of the nonmevalonate isopentenyl diphosphate synthesis pathway in Escherichia coli enhances lycopene production. Biotechnology and Bioengineering, 72,408-415.
46. Wang, G.-Y. and Keasling, J.D. (2002) Amplification of HMG-CoA reductase production enhances carotenoid accumulation in Neurospora crassa. Metabolic Engineering, 4,193-201.
47. Martin, V.J.J., Pitera, D.J., Withers, S.T. et al. (2003) Engineering a mevalonate pathway in Escherichia coli for production of terpenoids. Nature Biotechnology, 21,796-802.
48. McDaniel, R., Licari, P. and Khosla, C. (2001) Process development and metabolic engineering for the overproduction of natural and unnatural polyketides in Metabolic Engineering, vol. 73 (ed. l. Nielsen), Springer, Berlin, pp. 31-52.
49. Kealey, J.T., Liu, L., Santi, D.V. et al. (1998) Production of a polyketide natural product in nonpolyketide-producing prokaryotic and eukaryotic hosts. Proceedings of the National Academy of Sciences of the United States of America, 95,505-509.
50. Khosla, C.Z.R. (1996) Generation of polyketide libraries via combinatorial biosynthesis. Trends in Biotechnology, 14,335-341.
51. Reeves, A.R., Cernota, W.H., Brikun, I.A. et al. (2004) Engineering precursor flow for increased erythromycin production in Aeromicrobium erythreum. Metabolic Engineering, 6,300-312.
52. Reeves, A.R., Brikun, I.A., Cernota, W.H. et al. (2006) Effects of methylmalonyl-CoA mutase gene knockouts on erythromycin production in carbohydrate-based and oil-based fermentations of Saccharopolyspora ery-thraea. Journal of Industrial Microbiology and Biotechnology, 33,600-609.
53. Oliynyk, M., Samborskyy, M., Lester, J.B. et al. (2007) Complete genome sequence of the erythromycin-producing bacterium Saccharopolyspora erythraea NRRL23338. Nature Biotechnology, 25,447-453.
54. Mutka, S.C., Bondi, S.M., Carney, J.R. et al. (2006) Metabolic pathway engineering for complex polyketide biosynthesis in Saccharomyces cerevisiae. FEMS Yeast Research, 6,40-47.
55. Donadio, S., Staver, M.J., McAlpine, J.B. et al. (1991) Modular organization of genes required for complex polyketide biosynthesis. Science, 252,675-679.
56. Nielsen, J. (1998) The role of metabolic engineering in the production of secondary metabolites. Current Opinion in Microbiology, 1,330-336.
57. Pohl, N.L. (2002) Nonnatural substrates for polyketide synthases and their associated modifying enzymes. Current Opinion in Chemical Biology, 6,773-778.
58. Pfeifer, B.A., Admiraal, S.J., Gramajo, H. et al. (2001) Biosynthesis of complex polyketides in a metabolically engineered strain of E. coli. Science, 291,1790-1792.
59. Pfeifer, B., Hu, Z., Licari, P. and Khosla, C. (2002) Process and metabolic strategies for improved production of Escherichia coli-derived 6-deoxyerythronolide B. Applied and Environmental Microbiology, 68,3287-3292.
60. Lau, J., Tran, C., Licari, P. and Galazzo, J. (2004) Development of a high cell-density fed-batch bioprocess for the heterologous production of 6-deoxyerythronolide B in Escherichia coli. Journal ofBiotechnology, 110,95-103.
61. Murli, S., Kennedy, J., Dayem, L.C. et al. (2003) Metabolic engineering of Escherichia coli for improved 6-deoxyerythronolide B production. Journal of Industrial Microbiology and Biotechnology, 30 500-509.
62. Avignone Rossa, C., White, J., Kuiper, A. et al. (2002) Carbon flux distribution in antibiotic-producing chemostat cultures of Streptomyces lividans. Metabolic engineering, 4,138-150.
63. Takano, E., Gramajo, H.C., Strauch, E. et al. (1992) Transcriptional regulation of the redD transcriptional activator gene accounts for growth-phase-dependent production of the antibiotic undecylprodigiosin in Streptomyces coelicolor A3(2). Molecular Microbiology, 6,2797-2804.
64. Butler, M.J., Bruheim, P., Jovetic, S. et al. (2002) Engineering of primary carbon metabolism for improved antibiotic production in Streptomyces lividans. Applied and Environmental Microbiology, 68,4731-4739.
65. Mijts, B.N. and Schmidt-Dannert, C. (2003) Engineering of secondary metabolite pathways. Current Opinion in Biotechnology, 14,597-602.
66. Yoon, Y.J., Beck, B.J., Kim, B.S. et al. (2002) Generation of multiple bioactive macrolides by hybrid modular polyketide synthases in Streptomyces venezuelae. Chemistry & Biology, 9,203-214.
67. Hutchinson, C.R. (1998) Combinatorial biosynthesis for new drug discovery. Current Opinion in Microbiology, 1,319-329.
68. Menzella, H.G., Reid, R., Carney, J.R. et al. (2005)Combinatorialpolyketidebiosynthesisbydenovodesignand rearrangement of modular polyketide synthase genes. Nature Biotechnology, 23,1171-1176.
69. Jacobsen, J.R., Hutchinson, C.R., Cane, D.E. and Khosla, C. (1997) Precursor-directed biosynthesis of erythromycin analogs by an engineered polyketide synthase. Science, 277,367-369.
70. Ward, S.L., Desai, R.P., Hu, Z. et al. (2007) Precursor-directed biosynthesis of 6-deoxyerythronolide B analogues is improved by removal of the initial catalytic sites of the polyketide synthase. Journal ofIndustrial Microbiology and Biotechnology, 34,9-15.
71. Thykaer, J. and Nielsen, J. (2003) Metabolic engineering of β-lactam production. Metabolic Engineering, 5,56-69.
72. Nielsen, J. (1998) The role of metabolic engineering in the production of secondary metabolites. Current Opinion in Microbiology, 1,330-336.
73. Spratt, B.G. (1994) Resistance of antibiotics mediated by target alterations. Science, 264,388-393.
74. Reading, C. and Cole, M. (1977) Clavulanic acid: a beta-lactamase-inhibiting beta-lactam from Streptomyces clavuligerus. Antimicrobial Agents and Chemotherapy, 11,852-857.
75. Demain, A.L. and Vaishnav, P. (2006) Involvement of nitrogen-containing compounds in β-lactam biosynthesis and its control. Critical Reviews in Biotechnology, 26,67-82.
76. Elander, R.P. (2003) Industrial production of β-lactam antibiotics. AppliedMicrobiology & Biotechnology, 61,385-392.
77. Tahlan, K., Park, H.U., Wong, A., Beatty, P.H. and Jensen, S.E. (2004) Two sets of paralogous genes encode the enzymes involved in the early stages of clavulanic acid and clavam metabolite biosynthesis in streptomyces clavuligenis. 48,930-939.
78. Bushell, M.E., Kirk, S., Zhao, H.-J. and Avignone-Rossa, C.A. (2006) Manipulation of the physiology of clavulanic acid biosynthesis with the aid of metabolic flux analysis. Enzyme and Microbial Technology, 39,149-157.
79. Ives, P.R. and Bushell, M.E. (1997) Manipulation of the physiology of clavulanic acid production in Streptomyces clavuligerus. Microbiology (Reading, England), 143,3573-3579.
80. Li, R. and Townsend, C.A. (2006) Rational strain improvement for enhanced clavulanic acid production by genetic engineering of the glycolytic pathway in Streptomyces clavuligerus. Metabolic Engineering, 8,240-252.
81. Aidoo, K.A., Wong, A., Alexander, D.C. et al. (1994) Cloning, sequencing and disruption of a gene from Streptomyces clavuligerus involved in clavulanic acid biosynthesis. Gene, 147,41-46.
82. Jensen, S.E., Elder, K.J., Aidoo, K.A. and Paradkar, A.S., (2000) Enzymes catalyzing the early steps of clavulanic acid biosynthesis are encoded by two sets of paralogous genes in Streptomyces clavuligerus. Antimicrobial Agents and Chemotherapy, 44,720-726.
83. Li, R., Khaleeli, N. and Townsend, C.A. (2000) Expansion of the clavulanic acid gene cluster: identification and in vivo functional analysis of three new genes required for biosynthesis of clavulanic acid by Streptomyces clavuligerus. The Journal of Bacteriology, 182,4087-4095.
84. Jensen, S.E., Paradkar, A.S., Mosher, R.H. et al. (2004) Five additional genes are involved in clavulanic acid biosynthesis in Streptomyces clavuligerus. Antimicrobial Agents and Chemotherapy, 48,192-202.
85. Perez-Llarena, F.J., Liras, P., Rodriguez-Garcia, A. and Martin, J.F. (1997)Aregulatory gene (ccaR) required for cephamycin and clavulanic acid production in Streptomyces clavuligerus: amplification results in overproduction of both beta-lactam compounds. The Journal of Bacteriology, 179,2053-2059.
86. Hung, T.V., Malla, S., Park, B.C. et al. (2007) Enhancement of clavulanic acid by replicative and integrative expression of ccaR and cas2 in Streptomyces clavuligerus NRRL3585. Journal of Microbiology and Biotechnology, 17,1538-1545.
87. Wang, G., Tang, W. and Bidigare, R.R. (2005) Terpenoids as Therapeutic Drugs and Pharmaceutical (eds L. Zhang and A.L. Demain), The Humana Press, Totowa, NJ.
88. Chang, M.C.Y. and Keasling, J.D. (2006) Production of isoprenoid pharmaceuticals by engineered microbes. Nature Chemical Biology, 2,674-681.
89. Roberts, S.C. (2007) Production and engineering ofter penoids inplant cell culture. Nature Chemical Biology, 3,387-395.
90. Rohmer, M., Seemann, M., Horbach, S. et al. (1996) Glyceraldehyde 3-phosphate and pyruvate as precursors of isoprenic units in an alternative non-mevalonate pathway for terpenoid biosynthesis. Journal of the American Chemical Society, 118,2564-2566.
91. Lange, B.M., Rujan, T., Martin, W. and Croteau, R. (2000) Isoprenoid biosynthesis: the evolution of two ancient and distinct pathways across genomes. Proceedings of the National Academy of Sciences of the United States of America, 97,13172-13177.
92. Lois, L.M., Campos, N., Putra, S.R. et al. (1998) Cloning and characterization of a gene from Escherichia coli encoding a transketolase-like enzyme that catalyzes the synthesis of D-1-deoxyxylulose 5-phosphate, a common precursor for isoprenoid, thiamin, and pyridoxol biosynthesis. Proceedings of the National Academy of Sciences of the United States of America, 95,2105-2110.
93. Rohdich, F., Zepeck, F., Adam, P. et al. (2003) The deoxyxylulose phosphate pathway of isoprenoid biosynthesis: studies on the mechanisms of the reactions catalyzed by IspG and IspH protein. Proceedings of the National Academy of Sciences of the United States of America, 100,1586-1591.
94. Rodríguez-Concepción, M., Campos, N., Lois, L.M. et al. (2000) Genetic evidence of branching in the isoprenoid pathway for the production of isopentenyl diphosphate and dimethylallyl diphosphate in Escherichia coli. FEBS Letters, 473,328-332.
95. Rohdich, F., Wungsintaweekul, J., Fellermeier, M. et al. (1999) Cytidine 5'-triphosphate-dependent biosynthesis of isoprenoids: YgbP protein of Escherichia coli catalyzes the formation of 4-diphosphocy-tidyl-2-C-methylerythritol. Proceedings of the National Academy of Sciences of the United States of America, 96,11758-11763.
96. Luttgen, H., Rohdich, F., Herz, S. et al. (2000) Biosynthesis of terpenoids: YchB protein of Escherichia coli phosphorylates the 2-hydroxy group of 4-diphosphocytidyl-2C-methyl-D-erythritol. Proceedings of the National Academy of Sciences of the United States of America, 97,1062-1067.
97. Herz, S., Wungsintaweekul, J., Schuhr, C.A. et al. (2000) Biosynthesis of terpenoids: YgbB protein converts 4-diphosphocytidyl-2C-methyl-D-erythritol 2-phosphate to 2C-methyl-D-erythritol 2,4-cyclodiphosphate. Proceedings of the National Academy of Sciences of the United States of America, 97,2486-2490.
98. Maury, J., Asadollahi, M.A., Møller, K. et al. (2005) Microbial isoprenoid production: an example of green chemistry through metabolic engineering. Advances in Biochemical Engineering/Biotechnology, 100,19-51.
99. Withers, S.T. and Keasling, J.D. (2007) Biosynthesis and engineering of isoprenoid small molecules. Applied Microbiology and Biotechnology, 73,980-990.
100. Pitera, D.J., Paddon, C.J., Newman, J.D. and Keasling, J.D. (2007) Balancing a heterologous mevalonate pathway for improved isoprenoid production in Escherichia coli. Metabolic Engineering, 9,193-207.
101. Snow, R.W., Guerra, C.A., Noor, A.M. et al. (2005) The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature, 434,214-217.
102. Mercke, P., Bengtsson, M., Bouwmeester, H.J. et al. (2000) Molecular cloning, expression, and characterization of amorpha-4,11-diene synthase, a key enzyme of artemisinin biosynthesis in Artemisia annua L. Archives of Biochemistry and Biophysics, 381,173-180.
103. Sono, M., Roach, M.P., Coulter, E.D. and Dawson, J.H. (1996) Heme-containing oxygenases. Chemical Reviews, 96,2841-2888.
104. Chapple, C. (1998) Molecular-genetic analysis of plant cytochrome P450-dependent monooxygenases. Annual Review of Plant Physiology and Plant Molecular Biology, 49,311-343.
105. Chang, M.C.Y., Eachus, R.A., Trieu, W. et al. (2007) Engineering Escherichia coli for production of functionalized terpenoids using plant P450s. Nature Chemical Biology, 3,274-277.
106. Leonard, E. and Koffas, M.A. (2007) Engineering of artificial plant cytochrome P450 enzymes for synthesis of isoflavones by Escherichia coli. Applied and Environmental Microbiology, 73,7246-7251.
107. Ro, D.-K., Paradise, E.M., Ouellet, M. et al. (2006) Production of the antimalarial drug precursor artemisinic acid in engineered yeast. Nature, 440,940-943.
108. Das, A., Yoon, S.-H., Lee, S.-H. et al. (2007) An update on microbial carotenoid production: application of recent metabolic engineering tools. Applied Microbiology and Biotechnology, 77,505-512.
109. Demmig-Adams, B. and Adams, W.W. III (2002) Antioxidants in photosynthesis and human nutrition. Science, 298,2149-2153.
110. Klein-Marcuschamera, D., Ajikumara, P.K. and Stephanopoulos, G. (2007) Engineering microbial cell factories for biosynthesis of isoprenoid molecules: beyond lycopene. Trends in Biotechnology, 25,417-424.
111. Nimsa, E., Duboisb, C.P., Robertsa, S.C. and Walker, E.L. (2006) Expression profiling of genes involved in paclitaxel biosynthesis for targeted metabolic engineering. Metabolic Engineering, 8,385-394.
112. Rowinsky, E.K. and Donehower, R.C. (1995) Paclitaxel (Taxol). The New England Journal of Medicine, 332,1004-1014.
113. Wani, M.C.,Taylor, H.L.,Wall,M.E. et al. (1971) Plantantitumoragents. VI. Isolationand structureofTaxol, a novel antileukemic and antitumor agent from Taxus brevifolia. Journal of theAmerican Chemical Society, 93,2325-2327.
114. Wang, M., Cornett, B., Nettles, J. et al. (2000) The oxetane ring in taxol. The Journal of Organic Chemistry, 65,1059-1068.
115. Koepp, A.E., Hezari, M., Zajicek, J. et al. (1995) Cyclization of geranylgeranyl diphosphate to taxa-4 (5),11(12)-diene is the committed step of Taxol biosynthesis in Pacific yew. Journal of Biological Chemistry, 270,8686-8690.
116. Eisenreich, W., Menhard, B., Hylands, P.J. et al. (1996) Studies onthe biosynthesis ofTaxol: the taxane carbon skeleton is not of mevalonoid origin. Proceedings of the NationalAcademy of Sciences ofthe United States of America, 93,6431-6436.
117. Hezari, M. and Croteau, R. (1997) Taxol biosynthesis: an update. Planta Medica, 63,291-295.
118. Jennewein, S., Long, R.M., Williams, R.M. and Croteau, R. (2004) Cytochrome P450 taxadiene 5α-hydroxy-lase, a mechanistically unusual monooxygenase catalyzing the first oxygenation step of Taxol biosynthesis. Chemistry & Biology, 11,379-387.
119. Walker, K., Schoendorf, A. and Croteau, R. (2000) Molecular cloning of a taxa-4(20),11(12)-dien-5α-ol-O-acetyl transferase cDNA from Taxus and functional expression in Escherichia coli. Archives of Biochemistry and Biophysics, 374,371-380.
120. Walker, K. and Croteau, R. (2000) Taxol biosynthesis: molecular cloning of a benzoyl-CoA:taxane 2a-O-benzoyltransferase cDNA from Taxus and functional expression in Escherichia coli. Proceedings of the National Academy of Sciences of the United States of America, 97,13591-13596.
121. Walker, K. and Croteau, R. (2000) Molecular cloning of a 10-deacetylbaccatin III-10-O-acetyl transferase cDNA from Taxus and functional expression in Escherichia coli. Proceedings of the National Academy of Sciences of the United States of America, 97,583-587.
122. Walker, K., Fujisaki, S., Long, R. and Croteau, R. (2002) Molecular cloning and heterologous expression of the C-13 phenylpropanoid side chain-CoA acyltransferase that functions in Taxol biosynthesis. Proceedings ofthe National Academy ofSciences ofthe United States of America, 99,12715-12720.
123. Frense, D. (2007) Taxanes: perspectives for biotechnological production. Applied Microbiology and Biotechnology, 73,1233-1240.
124. Yukimune, Y., Tabata, H., Higashi, Y. and Hara, Y. (1996) Methyl jasmonate-induced overproduction of paclitaxel and baccatin III in Taxus cell suspension cultures. Nature Biotechnology, 14,1129-1132.
125. Wang, C., Wu, J. and Mei, X. (2001) Enhancement of Taxol production and excretion in Taxus chinensis cell culture by fungal elicitation and medium renewal. Applied Microbiology and Biotechnology, 55,404-410.
126. Qian, Z., Zhao, Z., Xu, Y. et al. (2006) Taxanes: perspectives for biotechnological production. Applied Microbiology and Biotechnology, 73,1233-1240.
127. Ketchum, R.E.B., Wherland, L. and Croteau, R.B. (2007) Stable transformation and long-term maintenance of transgenic Taxus cell suspension cultures. Plant Cell Reports, 26,1025-1033.
128. Besumbes, Ó., Sauret-Güeto, S., Phillips, M.A. et al. (2004) Metabolic engineering ofisoprenoidbiosynthesisin Arabidopsis for the production of taxadiene, the first committed precursor of Taxol. Biotechnology and Bioengineering, 88,168-175.
129. Kovacs, K., Zhang, L., Linforth, R.S.T. et al. (2007) Redirection of carotenoid metabolism for the efficient production oftaxadiene [taxa-4(5),11(12)-diene] in transgenic tomato fruit. Transgenic Research, 16,121-126.
130. Navia-Osorio, A., Garden, H., Cusido, R.M. et al. (2002) Production of paclitaxel and baccatin III in a 20-L airlift bioreactor by a cell suspension of Taxus wallichiana. Planta Medica, 68,336-340.
131. Huang, Q., Roessner, C.A., Croteau, R. and Scott, A.I. (2001) Engineering Escherichia coli forthe synthesis of taxadiene, a key intermediate in the biosynthesis of Taxol. Bioorganic & Medicinal Chemistry, 9,2237-2242.
132. Dejong, J.M., Liu, Y., Bollon, A.P. et al. (2006) Genetic engineering of taxol biosynthetic genes in Saccharo-myces cerevisiae. Biotechnology and Bioengineering, 93,212-224.